Cargando…
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
RATIONALE: There are no validated measures of disease activity in COPD. Since “active” disease is expected to have worse outcomes (e.g. mortality), we explored potential markers of disease activity in patients enrolled in the ECLIPSE cohort in relation to 8-year all-cause mortality. METHODS: We inve...
Autores principales: | Celli, Bartolome, Locantore, Nicholas, Yates, Julie C., Bakke, Per, Calverley, Peter M.A., Crim, Courtney, Coxson, Harvey O., Lomas, David A., MacNee, William, Miller, Bruce E., Mullerova, Hana, Rennard, Stephen I., Silverman, Edwin K., Wouters, Emiel, Tal-Singer, Ruth, Agusti, Alvar, Vestbo, Jørgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991608/ https://www.ncbi.nlm.nih.gov/pubmed/33303557 http://dx.doi.org/10.1183/13993003.01339-2020 |
Ejemplares similares
-
Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010) -
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
por: Agustí, Alvar, et al.
Publicado: (2012) -
A Genome-wide analysis of the response to inhaled beta2-agonists in Chronic Obstructive Pulmonary Disease
por: Hardin, Megan, et al.
Publicado: (2015) -
Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
por: Martin, Mickaël, et al.
Publicado: (2017) -
It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
por: McDonald, Merry-Lynn N., et al.
Publicado: (2019)